| Metric | Q2 2017 | Q1 2017 | Q2 2016 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $3.6B | — | — | — | — |
| Op. Income | $265M | — | — | — | — |
| Gross Margin | 16.9% | — | — | — | — |
| Net Margin | 4.2% | — | — | — | — |
| EPS (Diluted) | $0.57 | — | — | — | — |
| Free Cash Flow | $375M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $3.6B |
| Cost of Revenue | $3.0B |
| GROSS PROFIT | $608M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $343M |
| Other Expenses | $0 |
| Operating Expenses | $343M |
| Cost & Expenses | $3.3B |
| OPERATING INCOME | $265M |
| Interest Income | $0 |
| Interest Expense | $43M |
| Other Income/Expenses | -$50M |
| INCOME BEFORE TAX | $215M |
| Income Tax Expense | $62M |
| Net Income from Continuing Ops | $153M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $153M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $153M |
| D&A | $112M |
| EBIT | $258M |
| EBITDA | $370M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $3.6B |
| Cost of Revenue | $3.0B |
| GROSS PROFIT | $608M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $343M |
| Other Expenses | $0 |
| Operating Expenses | $343M |
| Cost & Expenses | $3.3B |
| OPERATING INCOME | $265M |
| Interest Income | $0 |
| Interest Expense | $43M |
| Other Income/Expenses | -$50M |
| INCOME BEFORE TAX | $215M |
| Income Tax Expense | $62M |
| Net Income from Continuing Ops | $153M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $153M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $153M |
| D&A | $112M |
| EBIT | $258M |
| EBITDA | $370M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $153M |
| Depreciation & Amortization | $112M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $8M |
| Other Non-Cash Items | $36M |
| Change in Working Capital | $151M |
| OPERATING CASH FLOW | $460M |
| Capital Expenditure | -$85M |
| Acquisitions (Net) | -$11M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $30M |
| NET CASH FROM INVESTING | -$66M |
| Net Debt Issuance | -$123M |
| Common Stock Repurchased | -$143M |
| Common Dividends Paid | -$5M |
| Other Financing Activities | $2M |
| NET CASH FROM FINANCING | -$269M |
| FREE CASH FLOW | $375M |
| Net Change in Cash | $1.1B |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1.1B |
| Short-Term Investments | $0 |
| Net Receivables | $1.2B |
| Inventory | $4.7B |
| Other Current Assets | $357M |
| TOTAL CURRENT ASSETS | $7.4B |
| PP&E (Net) | $2.7B |
| Goodwill | $2.3B |
| Intangible Assets | $0 |
| Long-Term Investments | $840M |
| Tax Assets | $0 |
| Other Non-Current Assets | $2.5B |
| TOTAL NON-CURRENT ASSETS | $8.4B |
| TOTAL ASSETS | $15.8B |
| Account Payables | $1.2B |
| Short-Term Debt | $362M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $2.4B |
| TOTAL CURRENT LIABILITIES | $4.0B |
| Long-Term Debt | $3.6B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $2.4B |
| TOTAL NON-CURRENT LIABILITIES | $6.1B |
| TOTAL LIABILITIES | $10.1B |
| Common Stock | $34M |
| Additional Paid-In Capital | $1.7B |
| Retained Earnings | $5.8B |
| Treasury Stock | -$329M |
| Accum. Other Comp. Income | -$1.5B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $5.7B |
| Minority Interest | $0 |
| TOTAL EQUITY | $5.7B |
| TOTAL LIABILITIES & EQUITY | $15.8B |
| Total Debt | $4.0B |
| Net Debt | $2.9B |
